Skip to main content
. 2021 Apr 2;106(8):e2953–e2967. doi: 10.1210/clinem/dgab216

Figure 4.

Figure 4.

Time to mortality for metreleptin-treated versus matched metreleptin-naïve Patients (GL Subgroup). Vertical bars denote censoring events. Abbreviation: GL, generalized lipodystrophy.